Back to VA Vanguard Capital Management LLC
GLUE2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Monte Rosa Therapeutics, Inc.
Yes. Vanguard Capital Management holds 3,412,927 shares of GLUE (Monte Rosa Therapeutics), worth $82.6M, as of its Q2 2026 13F filing. It increased the position by 312,682 shares (+10.1%) from Q1 2026. Vanguard Capital Management has held GLUE in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$82.6M
Current Shares
3.4M
Total Value Change
+$31.6M
Total Shares Change
+312,682
Quarter-by-Quarter History
Other major holders of GLUE: T. Rowe Price Associates, Inc., BlackRock, Inc., FMR LLC